Security key
14159C103
Cardio Diagnostics Holdings, Inc. - COMMON STOCK (CDIO)
CUSIP: 14159C103
Q2 2024 13F Holders as of 30 Jun 2024
- Security type / class
- Equity / COMMON STOCK
- Total 13F shares
- 1,811,145
- Total 13F value
- $996,125
- Share change
- +188,722
- SEC-reported price per share
- $0.55
- Number of holders
- 16
- Value change
- +$93,240
- Number of buys
- 9
- Number of sells
- 2
Report period
Q2 2024
Institutions
16
Top holders
10
CDIO full security history
Ownership snapshot
Full 13F holder table
Cardio Diagnostics Holdings, Inc. SEC filings
Cardio Diagnostics Holdings, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of CDIO - Cardio Diagnostics Holdings, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BlackRock Finance, Inc.
Disclosed value leader
BlackRock Finance, Inc.
Comparable rows
0/15
Latest evidence
31 Mar 2024
13F
3/4/5
Highest disclosed value: $1,515,228
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
BlackRock Finance, Inc. has the largest disclosed position value at $1.52M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BlackRock Finance, Inc.'s linked filing trail.
Disclosed position value
Top 5
BlackRock Finance, Inc.
$1.52M
Warren Hosseinion
$1.06M
Khullani Abdullahi
$641.7K
Elisa Luqman V
$558.8K
VANGUARD GROUP INC
$329.6K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BlackRock Finance, Inc. |
13F
Company
|
—
denominator unverified
|
$1,515,228
1,067,062 shares
|
— | 31 Mar 2024 |
| Warren Hosseinion |
3/4/5
Director
|
—
denominator unverified
|
$1,059,631
502,195 shares
|
— | 23 Jan 2024 |
| Khullani Abdullahi |
3/4/5
VP of Revenue and Strategy
|
—
denominator unverified
|
$641,710
304,128 shares
|
— | 23 Jan 2024 |
| Elisa Luqman V |
3/4/5
Chief Financial Officer
|
—
denominator unverified
|
$558,796
264,832 shares
|
— | 23 Jan 2024 |
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$329,637
232,139 shares
|
— | 31 Mar 2024 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
—
denominator unverified
|
$216,254
152,292 shares
|
— | 31 Mar 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
16
Shares
1,811,145
Rows available
16
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
14
Q2 2024 holders
16
Holder diff
2
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 value | Q2 2024 value | Value change | Value Chg % |
|---|